Compounds > oxprenolol
Page last updated: 2024-11-02

oxprenolol and Fetal Growth Restriction

oxprenolol has been researched along with Fetal Growth Restriction in 2 studies

Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandström, B1
Lubbe, WF1
Hodge, JV1
Kellaway, GS1

Other Studies

2 other studies available for oxprenolol and Fetal Growth Restriction

ArticleYear
Clinical trials of adrenergic antagonists in pregnancy hypertension.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 118

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt

1984
Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80.
    The New Zealand medical journal, 1982, Jan-13, Volume: 95, Issue:699

    Topics: Antihypertensive Agents; Bed Rest; Benzothiadiazines; Birth Weight; Diuretics; Drug Therapy, Combina

1982